Skip to main content
Caplight Logo









HIROTSU BIO SCIENCE INC.

HIROTSU BIO SCIENCE INC.

Private
TokyoHealthcare & Life Scienceshttps://hbio.jp/

Last Round

Corporate Funding

Mar 31, 2025

Est. Valuation

$948.77M

Total Funding Raised

$18.03M

Company Overview

HIROTSU BIO SCIENCE INC. is a biotechnology company that developed N-NOSE, a cancer screening test that utilizes the olfactory sensory functions of nematodes to detect cancer from urine samples.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Precision Medicine

Business Model

B2C

Customer Profile

Usage-Based SaaS, Government Contracts

AI Layer

Application

Keywords

cancer screeningnon-invasive cancer screeningearly cancer detectionmulti-cancer screeningliquid biopsynematode diagnosticsurine test for cancerat-home cancer testbiological diagnosticscancer screening kitmedical diagnosticsworm cancer testpancreatic cancer testAI-augmented diagnosticscorporate wellnessveterinary diagnosticscanine cancer screening

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

HIROTSU BIO SCIENCE INC. Comparables

Compare HIROTSU BIO SCIENCE INC. with similar companies based on industry and business-model similarity.

HIROTSU BIO SCIENCE INC. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Craif Inc.
76%
Blue Industries
75%
GRAIL
72%

HIROTSU BIO SCIENCE INC. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Corporate FundingMar 31, 2025
Corporate FundingAug 2, 2024
Corporate FundingDec 1, 2023
Corporate FundingAug 23, 2022
Corporate FundingMar 11, 2022
Corporate Funding
Feb 16, 2021

Key People

Founding team and executive leadership

Takaaki Hirotsu

代表取締役, 代表取締役CEO

Executive Team

Eric di Luccio

CTO, Executive Director, Head Of R&D Department, Chief Technology Officer (CTO), Head Of R&D Center

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 31, 2025

    Completed a corporate funding round.

  • Aug 2, 2024

    Received funding from Eastern Car Liner, Ltd.

HIROTSU BIO SCIENCE INC. Filings

Explore SEC and related filing metadata, where available.

HIROTSU BIO SCIENCE INC. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about HIROTSU BIO SCIENCE INC.'s valuation, stock price, and market status.

Is HIROTSU BIO SCIENCE INC. a public or private company?

HIROTSU BIO SCIENCE INC. is a private company.

What is the current stock price of HIROTSU BIO SCIENCE INC.?

HIROTSU BIO SCIENCE INC. is a private company with no public stock price. No recent secondary market data is available.

How much is HIROTSU BIO SCIENCE INC. worth (valuation)?

Valuation information for HIROTSU BIO SCIENCE INC. is not publicly available.

Can I buy HIROTSU BIO SCIENCE INC. stock?

HIROTSU BIO SCIENCE INC. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was HIROTSU BIO SCIENCE INC.'s last funding round?

Funding round information for HIROTSU BIO SCIENCE INC. is not publicly available.

Who are the main investors in HIROTSU BIO SCIENCE INC.?

Investor information for HIROTSU BIO SCIENCE INC. is not publicly disclosed.

Will HIROTSU BIO SCIENCE INC. IPO soon?

No public IPO plans have been announced for HIROTSU BIO SCIENCE INC..

How can I track HIROTSU BIO SCIENCE INC. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor HIROTSU BIO SCIENCE INC.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersTokyo
Employee Range14
Year Founded2016
Last FundingMar 31, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?